[Effectiveness of long-acting interferon (peginterferon)]

Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):515-8.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Antiviral Agents / administration & dosage*
  • Antiviral Agents / pharmacokinetics
  • Carcinoma, Hepatocellular / etiology
  • Carcinoma, Hepatocellular / prevention & control
  • Drug Therapy, Combination
  • Genotype
  • Hepacivirus / genetics
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / virology
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage*
  • Interferon-alpha / pharmacokinetics
  • Liver Cirrhosis / etiology
  • Liver Cirrhosis / prevention & control
  • Liver Neoplasms / etiology
  • Liver Neoplasms / prevention & control
  • Polyethylene Glycols / administration & dosage*
  • Polyethylene Glycols / pharmacokinetics
  • Randomized Controlled Trials as Topic
  • Recombinant Proteins
  • Ribavirin / administration & dosage
  • Time Factors
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2b
  • peginterferon alfa-2a